Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial

Radiotherapy and Oncology

Volumn 108, Issue 3, 2013, Pages 517-522

  Rademakers, Saskia E ^a   Hoogsteen, Ilse J ^a   Rijken, Paul F ^a   Oosterwijk, Egbert ^a   Terhaard, Chris H ^b   Doornaert, Patricia A ^c   Langendijk, Johannes A ^d   Van Den Ende, Piet ^e   Takes, Robert ^a   De Bree, Remco ^c   Van Der Kogel, Albert J ^a   Bussink, Johan ^a   Kaanders, Johannes H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ARCON; CAIX; Hypoxia; Laryngeal cancer

Indexed keywords

CARBOGEN; HYPOXIA ASSOCIATED PROTEIN; NICOTINAMIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACCELERATED RADIOTHERAPY WITH CARBOGEN BREATHING AND NICOTINAMIDE; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TREATMENT RESPONSE; TUMOR BIOPSY;

ARCON; CAIX; HYPOXIA; LARYNGEAL CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBON DIOXIDE; CARBONIC ANHYDRASES; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NIACINAMIDE; NITROIMIDAZOLES; OXYGEN; PROGNOSIS; TREATMENT OUTCOME;

EID: 84887025550     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.04.022     Document Type: Article

References (37)

1. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24
2. J.H. Kaanders, K.I. Wijffels, and H.A. Marres Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res 62 2002 7066 7074
3. S.E. Rademakers, P.N. Span, J.H. Kaanders, F.C. Sweep, A.J. van der Kogel, and J. Bussink Molecular aspects of tumour hypoxia Mol Oncol 2 2008 41 53
4. C.P. Potter, and A.L. Harris Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer Br J Cancer 89 2003 2 7
5. G.O. Janssens, S.E. Rademakers, and C.H. Terhaard Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial J Clin Oncol 30 2012 1777 1783
6. S.E. Rademakers, P.F. Rijken, and W.J. Peeters Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers Cell Oncol (Dordr) 34 2011 119 129
7. I.J. Hoogsteen, H.A.M. Marres, and K.I.E.M. Wijffels Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma Clin Cancer Res 11 2005 97 106
8. K.I. Wijffels, J.H. Kaanders, and P.F. Rijken Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas Br J Cancer 83 2000 674 683
9. N.J. Beasley, C.C. Wykoff, and P.H. Watson Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density Cancer Res 61 2001 5262 5267
10. R.A. Jonathan, K.I. Wijffels, and W. Peeters The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON Radiother Oncol 79 2006 288 297
11. A. Mayer, M. Hockel, and P. Vaupel Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix Clin Cancer Res 11 2005 7220 7225
12. J.A. Loncaster, A.L. Harris, and S.E. Davidson Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix Cancer Res 61 2001 6394 6399
13. I.J. Hoogsteen, J. Lok, and H.A. Marres Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia Eur J Cancer 45 2009 2906 2914
14. E.G. Troost, J. Bussink, and J.H. Kaanders Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines Radiother Oncol 76 2005 194 199
15. P.N. Span, J. Bussink, P. Manders, L.V. Beex, and C.G. Sweep Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome Br J Cancer 89 2003 271 276
16. M.H. Bui, D. Seligson, and K.R. Han Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy Clin Cancer Res 9 2003 802 811
17. C.A. Brewer, S.Y. Liao, and S.P. Wilczynski A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN Gynecol Oncol 63 1996 337 344
18. S.J. Kim, H.J. Shin, and K.Y. Jung Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue Jpn J Clin Oncol 37 2007 812 819
19. M.L. Schrijvers, B.F. van der Laan, and G.H. de Bock Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy Int J Radiat Oncol Biol Phys 72 2008 161 169
20. A.W. Eckert, M.H. Lautner, and A. Schutze Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients J Oral Pathol Med 39 2010 313 317
21. M.M. Vleugel, A.E. Greijer, and A. Shvarts Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer J Clin Pathol 58 2005 172 177
22. C.C. Wykoff, N.J. Beasley, and P.H. Watson Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res 60 2000 7075 7083
23. A.B. Stillebroer, P.F. Mulders, O.C. Boerman, W.J. Oyen, and E. Oosterwijk Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy Eur Urol 58 2010 75 83
24. M.H. Bui, H. Visapaa, and D. Seligson Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma J Urol 171 2004 2461 2466
25. T. Klatte, D.B. Seligson, and S.B. Riggs Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma Clin Cancer Res 13 2007 7388 7393
26. H. Zhong, K. Chiles, and D. Feldser Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res 60 2000 1541 1545
27. R. Ihnatko, M. Kubes, and M. Takacova Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia Int J Oncol 29 2006 1025 1033
28. C. Willam, C. Warnecke, and J.C. Schefold Inconsistent effects of acidosis on HIF-alpha protein and its target genes Pflugers Arch 451 2006 534 543
29. B.S. Sorensen, J. Alsner, J. Overgaard, and M.R. Horsman Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH Radiother Oncol 83 2007 362 366
30. R. Ravi, B. Mookerjee, and Z.M. Bhujwalla Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha Genes Dev 14 2000 34 44
31. P.H. Maxwell, M.S. Wiesener, and G.W. Chang The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
32. M.L. Gillison, W.M. Koch, and R.B. Capone Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Nat Cancer Inst 92 2000 709 720
33. M.S. Greenblatt, W.P. Bennett, M. Hollstein, and C.C. Harris Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res 54 1994 4855 4878
34. P. Lassen The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome Radiother Oncol 95 2010 371 380
35. F.X. Bosch, D. Ritter, and C. Enders Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value Int J Cancer 111 2004 530 538
36. J.G. Eriksen, and J. Overgaard Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study Radiother Oncol 83 2007 383 388
37. L.M. Seeber, N. Horree, P. van der Groep, E. van der Wall, R.H. Verheijen, and P.J. van Diest Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma BMC Cancer 10 2010 307